Pathophysiology of the Clinical Manifestations of Preeclampsia

This publication has 67 references indexed in Scilit:

• Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
  New England Journal of Medicine, 2006
• Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one‐third of late third‐trimester pre‐eclamptic women
  Ultrasound in Obstetrics & Gynecology, 2005
• l -Arginine Attenuates Hypertension in Pregnant Rats With Reduced Uterine Perfusion Pressure
  Hypertension, 2004
• Circulating Angiogenic Factors and the Risk of Preeclampsia
  New England Journal of Medicine, 2004
• The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia
  Published by Wolters Kluwer Health ,2001
• Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension*1
  Published by Wolters Kluwer Health ,1999
• Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia
  Acta Obstetricia et Gynecologica Scandinavica, 1998
• l-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat
  American Journal of Obstetrics and Gynecology, 1996
• A CRITICAL EVALUATION OF RENAL PROTEIN SELECTIVITY IN PREGNANCY
  BJOG: An International Journal of Obstetrics and Gynaecology, 1974
• PROTEINURIA IN TOXAEMIA AND ABRUPTIO PLACENTAE
  BJOG: An International Journal of Obstetrics and Gynaecology, 1972